J Gynecol Oncol.  2014 Oct;25(4):306-312. 10.3802/jgo.2014.25.4.306.

Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients

• Tirumani S
• Deaver P
• Shinagare
• Tirumani H
• Hornick JL
• George S
• Ramaiya NH

• KMID: 2130119
• DOI: http://doi.org/10.3802/jgo.2014.25.4.306

Abstract

OBJECTIVE
To describe metastatic pattern of uterine leiomyosarcomas (ULMS) and correlate it with clinical and histopathologic parameters.
METHODS
We included 113 women (mean age, 53 years; range, 29 to 72 years) with histopathology-confirmed ULMS from 2000 to 2012. Distribution of metastases was noted from imaging by two radiologists in consensus. Predictors of development of metastases were analyzed with univariate and multivariate analysis. Impact of various clinical and histopathologic parameters on survival was compared using Log-rank test and Cox proportional hazard regression model.
RESULTS
Distant metastases were seen in 81.4% (92/113) of the patients after median interval of 7 months (interquartile range, 1 to 21). Lung was most common site of metastases (74%) followed by peritoneum (41%), bones (33%), and liver (27%). Local tumor recurrence was noted in 57 patients (50%), 51 of whom had distant metastases. Statistically significant correlation was noted between local recurrence and peritoneal metastases (p<0.001) and between lung and other common sites of hematogeneous metastases (p<0.05). Age, serosal involvement, local recurrence, and the International Federation of Gynecology and Obstetrics (FIGO) stage were predictive factors for metastases. At the time of reporting, 65% (74/113) of the patients have died; median survival was 45 months. Stage, local recurrence, and age were poor prognostic factors.
CONCLUSION
ULMS metastasizes most frequently to lung, peritoneum, bone, and liver. Local recurrence was associated with peritoneal spread and lung metastases with other sites of hematogeneous metastases. Age, FIGO stage and local recurrence predicted metastatic disease and advanced stage, older age and local recurrence predicted poor outcome.

Keyword

Leiomyosarcoma; Neoplasm recurrence; Prognosis; Proportional Hazards Models

MeSH Terms

Adult
Age Factors
Aged
Bone Neoplasms/secondary
Female
Humans
Leiomyosarcoma/pathology/*secondary/therapy
Liver Neoplasms/secondary
Lung Neoplasms/secondary
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Peritoneal Neoplasms/secondary
Prognosis
Retrospective Studies
Risk Factors
Survival Analysis
Treatment Outcome
Uterine Neoplasms/*pathology/therapy

Reference

1. Tirumani SH, Ojili V, Shanbhogue AK, Fasih N, Ryan JG, Reinhold C. Current concepts in the imaging of uterine sarcoma. Abdom Imaging. 2013; 38:397–411.

2. Abeler VM, Royne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway: a histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009; 54:355–364.

3. Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003; 89:460–469.

4. Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008; 112:820–830.

5. Bernstein-Molho R, Grisaro D, Soyfer V, Safra T, Merimsky O. Metastatic uterine leiomyosarcomas: a single-institution experience. Int J Gynecol Cancer. 2010; 20:255–260.

6. Gadducci A, Landoni F, Sartori E, Zola P, Maggino T, Lissoni A, et al. Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol. 1996; 62:25–32.

7. Mayerhofer K, Obermair A, Windbichler G, Petru E, Kaider A, Hefler L, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999; 74:196–201.

8. Alonso Gomez J, Arjona Sanchez A, Martinez Cecilia D, Diaz Nieto R, Roldan de la Rua J, Valverde Martinez A, et al. Uterine leiomyosarcoma metastasis to the pancreas: report of a case and review of the literature. J Gastrointest Cancer. 2012; 43:361–363.

9. Calleja AM, Wellnitz CV, Alharthi MS, Khandheria BK, Chaliki HP. Extensive cardiac metastases secondary to uterine leiomyosarcoma. J Am Soc Echocardiogr. 2009; 22:1419.e5–1419.e7.

10. Corcoran S, Hogan AM, Nemeth T, Bennani F, Sullivan FJ, Khan W, et al. Isolated cutaneous metastasis of uterine leiomyosarcoma: case report and review of literature. Diagn Pathol. 2012; 7:85.

11. Cordioli E, Pizzi C, Bugiardini R. Left ventricular metastasis from uterine leiomyosarcoma. Cardiologia. 1999; 44:1001–1003.

12. Erkal HS, Ozturk AS, Kutluay L, Aydin D. Endobronchial metastases from a leiomyosarcoma of the uterus. Tuberk Toraks. 2008; 56:92–95.

13. Gruttadauria S, Pagano D, Li Petri S, di Francesco F, Cintorino D, Gridelli B. Pancreatic metastases from uterine leiomyosarcoma with vascular involvement. Am Surg. 2011; 77:125–126.

14. Hsiao HH, Liu YC, Hou MF, Lin SF. Uterine leiomyosarcoma metastasis to the breast. Eur J Gynaecol Oncol. 2008; 29:191–192.

15. Melone GA, D'Elia A, Brogna C, Salvati M. Uterine leiomyosarcoma metastatic to the brain: case report. Tumori. 2008; 94:856–860.

16. Miglietta L, Canobbio L, Parodi MA, Anselmi L. Unusual osteoblastic secondary lesion as predominant metastatic disease spread in two cases of uterine leiomyosarcoma. Case Rep Oncol. 2010; 3:49–53.

17. Yamada S, Yamada SM, Nakaguchi H, Murakami M, Hoya K, Matsuno A. A case of multiple brain metastases of uterine leiomyosarcoma with a literature review. Surg Oncol. 2011; 20:e127–e131.

18. Raut CP, Nucci MR, Wang Q, Manola J, Bertagnolli MM, Demetri GD, et al. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. Eur J Cancer. 2009; 45:2818–2824.

19. Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, et al. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems. J Clin Oncol. 2009; 27:2066–2072.

20. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology Endometrial Cancer Version 1.2013 [Internet]. Fort Washington, PA: National Comprehensive Cancer Network;2014. cited 2014 Aug 20. Available from: http://www.nccn.org/.

21. Rose PG, Piver MS, Tsukada Y, Lau T. Patterns of metastasis in uterine sarcoma: an autopsy study. Cancer. 1989; 63:935–938.

22. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009; 104:177–178.

23. Iasonos A, Keung EZ, Zivanovic O, Mancari R, Peiretti M, Nucci M, et al. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Cancer. 2013; 119:1816–1822.